Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Career Development Award

    The Career Development Award supports early-career physician investigators through mentored, patient-oriented cancer research projects that help them build independent clinical oncology research programs.

    Browse similar grants
    Cancer Research Grants 2026Early Career Research Grants for New Faculty

    Funder: Conquer Cancer - the ASCO Foundation

    Due Dates: October 8, 2026 (Full application) | December 3, 2026 (Post-submission materials #1) | January 28, 2027 (Post-submission materials #2)

    Funding Amounts: $200,000 over three years, paid in annual installments of $66,666

    Summary: A mentored award helping clinical investigators establish independent, patient-oriented cancer research programs.

    Key Information: Applicants must commit at least 50% of their time to research throughout the award period.


    Description

    Conquer Cancer, the ASCO Foundation, offers the Career Development Award to physicians in their first four years of a full-time clinical faculty appointment who are establishing independent research careers in clinical oncology. Projects are conducted with an experienced scientific mentor. The award accepts applications from the United States and internationally, across all areas of cancer research.

    Research must involve human subjects and have a patient-oriented clinical or translational focus. Eligible approaches include epidemiologic and behavioral studies, quality-of-care research, outcomes research, and health services research; proposals focused predominantly on in vitro or animal studies are not allowed. Projects must be developed with a patient advocate, have measurable outcomes, and be feasible within the three-year term. Dedicated donor funding for 2027 includes palliative and supportive care in oncology and breast cancers.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.